MO01.41 Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

Autor:	Subramanian, J., Jaal, J., Kudaba, I., Nikolov, K., Radosavljevic, D., Csőszi, T., Xiao, J., Horton, J., Malik, R.K., Gómez, M.D.
Zdroj:	In Journal of Thoracic Oncology January 2021 16(1) Supplement:S33-S33
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu